Immunohistochemical Expression of Galectin-3 and MUC1 in Tumour Cells and Tumour-Associated Stromal Cells in Invasive Breast Carcinoma: Association with Clinicopathological Parameters
Author : Dr. Dommati Mounika, Dr. Yashita Gupta, Dr. Rakesh Kumar Gupta, Dr. Radhakrishna Ramchandani, Dr. Amit Kumar
Abstract : Background: Breast carcinoma progression is increasingly understood as tumour–stroma crosstalk rather than epithelial changes alone. Galectin-3 and MUC-1 regulate adhesion, invasion and metastasis, but their expression in cancer-associated fibroblasts (CAFs) remains underexplored. Aim: To evaluate Galectin-3 and MUC-1 expression in tumour-cells and CAFs by immunohistochemistry and correlate findings with clinicopathological parameters. Methods: Ambispective study included 100 cases of invasive breast carcinoma. Galectin-3 and MUC-1 were assessed using H-score and Immunoreactive-score, respectively, in tumour-cells and CAFs. Associations were analysed using chi-square, Mann–Whitney/ Kruskal–Wallis, Spearman correlation and multivariable logistic regression. Results: Tumour-cell Galectin-3 negativity increased with nodal burden (27.1% in pN0 vs 85.7% in pN2–3; p<0.001) and was associated with LVI (p=0.017). Conversely, high CAF Galectin-3 increased with nodal burden, LVI and PNI (all p<0.05), demonstrating an inverse tumour–stromal relationship. Tumour-cell MUC-1 expression showed limited clinicopathological associations; however, MUC-1 heterogeneity increased with nodal progression, from 20.8% in pN0 to 55.6% in pN1 and 76.2% in pN2–3 (p<0.001). Heterogeneity was associated with tumour-cell Galectin-3 (p=0.024) and CAF Galectin-3 (p=0.001). Low/negative tumour-cell Galectin-3 and high CAF Galectin-3 were associated with heterogeneous MUC-1 staining. An integrated biomarker score showed a graded association with nodal burden (p<0.001). Multivariable analysis identified low/negative tumour-cell Galectin-3, high CAF Galectin-3, MUC-1 heterogeneity and LVI as independent predictors of nodal metastasis. Conclusion: The significance of Galectin-3 and MUC-1 depends on cellular compartment, spatial distribution and heterogeneity rather than expression quantity alone. Compartment-based IHC assessment may provide a foundation for integrated prognostic biomarkers in practice.
Keywords : Invasive breast carcinoma, galectin-3, mucin-1, cancer-associated fibroblasts, tumour–stroma interaction, immunohistochemistry, nodal metastasis, lymphovascular invasion.
Conference Name : International Conference on Cancer Pathology (ICCPATH - 26)
Conference Place : Hyderabad, India
Conference Date : 18th Oct 2026